BM&FBovespa attempts to prevent competition in the country.
The president of the stock exchange, Edemir Pinto, will try to refute a study that points to benefits in the competition.
247 - BM&FBovespa wants to continue reigning supreme in the Brazilian capital market, even though the Securities and Exchange Commission advocates for competition.
At the request of the CVM (Brazilian Securities and Exchange Commission), a study was commissioned from the consulting firm Oxera, which indicated reductions of 25% to 40% in trading margins if the shares could be traded on another market.
This is what happens, for example, in the United States, where companies can trade their shares on the New York Stock Exchange or Nasdaq.
The president of BM&FBovespa, Edemir Pinto, however, argues that the Brazilian market is different from others. "Our costs are competitive," he said, admitting his "frustration" with the results of the Oxera study. According to him, the report lacked depth.
The question is: did the study truly lack depth, or is it simply a monopolistic desire on the part of BM&FBovespa?